Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial

Journal:

European Urology

Published:

2025-08-01

DOI:

10.1016/j.eururo.2025.07.006

Affiliations:

17

Authors:

31

Go to article

Institutions	Authors	Share
The University of Texas MD Anderson Cancer Center, United States of America (USA)	25.500000 25.500000 25.500000	0.82
Mayo Clinic, United States of America (USA)	2.500000	0.08
The University of Texas Health Science Center at San Antonio (UT Health San Antonio), United States of America (USA)	1.000000	0.03
Rutgers University - New Brunswick, United States of America (USA)	1.000000	0.03
University of Maryland, Baltimore (UMB), United States of America (USA)	1.000000	0.03

Interested in Oncology and Carcinogenesis?